60 Degrees Pharmaceuticals
UEI: WKN5DNLTVF95
• CAGE: 71D06
Overview
Parent Awardee
Company Description
60° Pharmaceuticals (60P)—a specialty pharmaceutical corporation dedicated to leading the way in the development and commercialization of infectious disease medicines for COVID-19, malaria, dengue and other infectious diseases.
Name
60 Degrees Pharmaceuticals
Website
Headquarters
Washington, DC
United States
United States
Most Recent Award
July 24, 2024
Calculating
Federal contract recipient
60 DEGREES PHARMACEUTICALS, INC.
(UEI WKN5DNLTVF95, CAGE 71D06)
is headquartered in Washington DC.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in July 2011 and
federally registered in
November 2013.
Federal Award Analysis
60 Degrees Pharmaceuticals federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
60 DEGREES PHARMACEUTICALS, INC.
UEI
WKN5DNLTVF95
CAGE Code
71D06
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
July 5, 2011
Initial Registration
Nov. 19, 2013
Last Registration
June 28, 2024
Registration Activation
June 28, 2024
Registration Expiration
June 26, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Reported PSC
Accepts Credit Cards
No
People
Vendor contacts at 60 Degrees Pharmaceuticals
GSA Schedules and Price Lists
- 60 Degrees Pharmaceuticals
- PoP: 2/14/20 - 8/14/25
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- 60 Degrees Pharmaceuticals
- PoP: 10/16/19 - 2/15/20 (Ended)